PRME PRIME MEDICINE INC

Ownership history in EcoR1 Capital, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which EcoR1 Capital, LLC reported a position in PRIME MEDICINE INC (PRME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.41% (2025 Q3)
Avg. % of fund
0.19%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,543,326 +843,326 +120.5% 0.41% $8.6M $5.54
2025 Q1 UNCHANGED 700,000 0% 0.08% $1.4M $1.99
2024 Q4 UNCHANGED 700,000 0% 0.08% $2.0M $2.92
2024 Q3 UNCHANGED 700,000 0% 0.09% $2.7M $3.87
2024 Q2 UNCHANGED 700,000 0% 0.11% $3.6M $5.14
2024 Q1 ADDED 700,000 +100,000 +16.7% 0.12% $4.9M $7.00
2023 Q3 UNCHANGED 600,000 0% 0.19% $5.7M $9.54
2023 Q2 UNCHANGED 600,000 0% 0.22% $8.8M $14.65
2023 Q1 UNCHANGED 600,000 0% 0.24% $7.4M $12.30
2022 Q4 INITIATED 600,000 0.34% $11.1M
% of Fund (quarterly)    PRME price (monthly, adj. close)
← Back to EcoR1 Capital, LLC Holdings